Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medical ImagingROCO:6637 90 EV-to-EBITDA is 5.72 as of Sep. 17, 2026, which is 60% below its 10-year median of 14.41. GuruFocus rates ROCO:6637 with a GF Score™ of 90/100 and a GF Value™ of NT$88.16 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 101 Medical Distribution companies, Medical Imaging ranks better than 68.32% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medical Imaging's enterprise value is NT$1,416.2 Mil.
Medical Imaging's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$247.8 Mil. Therefore, Medical Imaging's EV-to-EBITDA for today is 5.72.
The historical rank and industry rank for Medical Imaging's EV-to-EBITDA or its related term are showing as below:
ROCO:6637'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.4 Med: 14.41 Max: 23.29
Current: 5.71
During the past 12 years, the highest EV-to-EBITDA of Medical Imaging was 23.29. The lowest was 4.40. And the median was 14.41.
ROCO:6637's EV-to-EBITDA is ranked better than 68.32% of 101
companies
in the Medical Distribution industry
Industry Median: 8.47
vs ROCO:6637: 5.71
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Medical Imaging (ROCO:6637) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medical Imaging's PE Ratio (TTM) for today is calculated as:
Medical Imaging's share price for today is NT$54.00.
Medical Imaging's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$5.462.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Medical Imaging's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6637 vs MCK, COR, CAH: EV-to-EBITDA Comparison
For the Medical Distribution subindustry, Medical Imaging's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Imaging EV-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medical Imaging's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Medical Imaging's EV-to-EBITDA falls into.
Medical Imaging's current Enterprise Value is NT$1,416.2 Mil.
Medical Imaging's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$247.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Imaging (ROCO:6637) has a EV-to-EBITDA of 5.72 as of Sep. 17, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Medical Imaging. This is 60% below median its historical median of 14.41. Over the past decade, Medical Imaging's EV-to-EBITDA has ranged from 4.40 to 23.29. According to the industry distribution chart, Medical Imaging ranks #32 out of 101 companies in the Medical Distribution industry, placing it in the top 31.7%.
Is Medical Imaging's EV-to-EBITDA too high?
Medical Imaging's current EV-to-EBITDA of 5.72 is 60% below median its 10-year median of 14.41. Over the past 10 years, this metric has ranged from a low of 4.40 to a high of 23.29. The Medical Distribution industry median EV-to-EBITDA is 8.47. Medical Imaging's value of 5.72 is 32.5% below this industry median. Based on the distribution chart, Medical Imaging ranks #32 out of 101 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Medical Imaging has a GF Score™ of 90/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medical Imaging's EV-to-EBITDA compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Medical Imaging ranks #32 out of 101 companies for EV-to-EBITDA. This puts Medical Imaging in the upper half of its industry. The industry median EV-to-EBITDA is 8.47. Medical Imaging's value of 5.72 is 32.5% below this benchmark. Historically, Medical Imaging's own EV-to-EBITDA has ranged from 4.40 to 23.29 over the past decade. While the company's 10-year median is 14.41 vs. the industry median of 8.47, Medical Imaging has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Distribution company?
The median EV-to-EBITDA among Medical Distribution companies is 8.47, based on 101 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Imaging's current EV-to-EBITDA of 5.72 is 32.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Medical Imaging. For the Medical Distribution industry, the median EV-to-EBITDA is 8.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Imaging's current EV-to-EBITDA is 5.72, which is 60% below median its own 10-year median of 14.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Imaging stock overvalued right now?
Based on GuruFocus' analysis, Medical Imaging (ROCO:6637) is currently considered Possible Value Trap. The stock's GF Value™ is NT$88.16, compared to a current price of NT$54.00 — trading 38.7% below its estimated fair value. The current EV-to-EBITDA is 5.72, which is 60% below median its 10-year median of 14.41 and 32.5% below the Medical Distribution industry median of 8.47. Medical Imaging's overall GF Score™ is 90/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Medical Imaging (ROCO:6637), the current EV-to-EBITDA is 5.72 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Imaging (ROCO:6637) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Imaging stock appears to be undervalued.
The current stock price of NT$54.00 is trading 38.7% below its estimated GF Value™ of NT$88.16.
GuruFocus considers Medical Imaging to be Possible Value Trap.
Key valuation signals for ROCO:6637:
EV-to-EBITDA: 5.72 (60% below median its 10-year median of 14.41)
GF Value™: NT$88.16 vs. price of NT$54.00 (38.7% below fair value)
Industry Position: 32.5% below the Medical Distribution median (#32 of 101)
No single metric tells the full story. See the ROCO:6637 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Imaging Corp is a Taiwan based medical equipment company. It is engaged in medical equipment distribution, hospital equipment rental, and equipment maintenance.
90GF Score
Get the complete analysis for ROCO:6637
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6637 has been successfully added to your 
